Across TCGA pan-cancer cohorts, PIGY RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated PIGY data layer.
The strongest signal is observed in small cell lung cancer (SCLC), where higher PIGY RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated PIGY expression acts as an unfavorable survival marker.
SCLC are the cancer types where PIGY RNA most reproducibly stratifies survival.